Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RUSC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PLCXD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
COL18A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHST2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1683 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCARF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC157740 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
YWHAH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM259 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSBP1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GABRR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEKHH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM184A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK8IP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf60 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on